0Y5E Stock Overview
Provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Perrigo Company plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$27.07 |
| 52 Week High | US$34.24 |
| 52 Week Low | US$20.00 |
| Beta | 0.48 |
| 11 Month Change | 11.40% |
| 3 Month Change | -2.03% |
| 1 Year Change | -10.33% |
| 33 Year Change | -37.03% |
| 5 Year Change | -44.75% |
| Change since IPO | -70.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0Y5E | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 1.9% | 3.5% | -1.0% |
| 1Y | -10.3% | 0.4% | 6.9% |
Return vs Industry: 0Y5E underperformed the UK Pharmaceuticals industry which returned 0.4% over the past year.
Return vs Market: 0Y5E underperformed the UK Market which returned 6.9% over the past year.
Price Volatility
| 0Y5E volatility | |
|---|---|
| 0Y5E Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.1% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0Y5E has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0Y5E's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 9,140 | Patrick Lockwood-Taylor | www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Perrigo Company plc Fundamentals Summary
| 0Y5E fundamental statistics | |
|---|---|
| Market cap | US$3.67b |
| Earnings (TTM) | -US$146.90m |
| Revenue (TTM) | US$4.39b |
0.8x
P/S Ratio-25.0x
P/E RatioIs 0Y5E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0Y5E income statement (TTM) | |
|---|---|
| Revenue | US$4.39b |
| Cost of Revenue | US$2.81b |
| Gross Profit | US$1.58b |
| Other Expenses | US$1.73b |
| Earnings | -US$146.90m |
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.08 |
| Gross Margin | 36.07% |
| Net Profit Margin | -3.34% |
| Debt/Equity Ratio | 104.8% |
How did 0Y5E perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield-103%
Payout RatioDoes 0Y5E pay a reliable dividends?
See 0Y5E dividend history and benchmarks| Perrigo dividend dates | |
|---|---|
| Ex Dividend Date | Nov 29 2024 |
| Dividend Pay Date | Dec 17 2024 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 31 days |
Does 0Y5E pay a reliable dividends?
See 0Y5E dividend history and benchmarks